US · Healthcare

Biovaxys Technology Corp (BVAXF)

Biotechnology

Biovaxys Technology Corp (BVAXF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BVAXF

P/E ratio

18.00

Biovaxys Technology Corp (BVAXF) — FAQ

What is BVAXF's P/E ratio?

The price-to-earnings (P/E) ratio for Biovaxys Technology Corp (BVAXF) is 18.00 (data as of 2026-03-23).

Does Biovaxys Technology Corp pay a dividend?

Dividend yield is not available in the current snapshot for Biovaxys Technology Corp (BVAXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Biovaxys Technology Corp in?

Biovaxys Technology Corp (BVAXF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BVAXF listed on?

BVAXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)